The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Inducing and exploiting vulnerabilities for the treatment of liver cancer
Open accessAbstract
Liver cancer remains difficult to treat, owing to a paucity of drugs that target critical dependencies 1,2; broad-spectrum kinase inhibitors such as sorafenib provide only a modest benefit to patients with hepatocellular carcinoma 3. The induction of senescence may represent a strategy for the treatment of cancer, especially when combined with a second drug that selectively eliminates senescent cancer cells (senolysis)4,5. Here, using a kinome-focused genetic screen, we show that pharmacological inhibition of the DNA-replication kinase CDC7 induces senescence selectively in liver cancer cells with mutations in TP53. A follow-up chemical screen identified the antidepressant sertraline as an agent that kills hepatocellular carcinoma cells that have been rendered senescent by inhibition of CDC7. Sertraline suppressed mTOR signalling, and selective drugs that target this pathway were highly effective in causing the apoptotic cell death of hepatocellular carcinoma cells treated with a CDC7 inhibitor. The feedback reactivation of mTOR signalling after its inhibition 6 is blocked in cells that have been treated with a CDC7 inhibitor, which leads to the sustained inhibition of mTOR and cell death. Using multiple in vivo mouse models of liver cancer, we show that treatment with combined inhibition of of CDC7 and mTOR results in a marked reduction of tumour growth. Our data indicate that exploiting an induced vulnerability could be an effective treatment for liver cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Senescence induction by inhibition of DNA replication kinase CDC7 has also been paired with a senolytic that disrupts mTOR signaling, inducing apoptosis in senescent human liver cancer cells and improving survival in mouse models of HCC (Wang et al. 2019).”
From Senescence and the SASP: many therapeutic avenues (2020) · cites this paper as Wang et al. 2019
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Furthermore, many of the genes have been denoted as possible therapeutic targets in a variety of epithelial-based cancers, such as CDC7 in oral squamous carcinoma30 and liver cancer31, ATP1B3 in gastric cancer32, and FKBP14 in ovarian cancer33.”
From Exploiting convergent phenotypes to derive a pan-cancer cisplatin response gene expression signature (2023) · cites this paper as [31]
The cited source says what the claim attributes to it.
In the citing paper
“In a mouse model of liver cancer, the mTOR inhibitor AZD8055 also showed senolytic potential against cancer cells with senescence induced by small- molecule inhibitors of CDC7 (ref. 207 ) .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [207]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Elevated expression of p16 in melanocytes156 and epidermal and dermal cells157,158 is associated with human aging.”
From Guidelines for minimal information on cellular senescence experimentation in vivo (2024) · cites this paper as [156]
Experimental — accuracy not yet measuredIn the citing paper
“Based on the preclinical experimental evidence enumerated here, approaches based on the induction of senescence in large fraction of tumors have the potential to enter the realm of the clinical practice, even more if combined with adjuvant immunotherapy or senolytic therapy to remove potentially harmful senescent escaper variants, as recently proposed.189,202,203”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [202]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
Llovet, J. M., Kelley, R. K., Villanueva, A., Singal, A. G., Pikarsky, E., Roayaie, S., Lencioni, R., Koike, K., Zucman-Rossi, J., & Finn, R. S. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00240-3 · Cited by 7,055
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
Llovet, J. M., Zucman-Rossi, J., Pikarsky, E., Sangro, B., Schwartz, M., Sherman, M., & Gores, G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.18 · Cited by 2,531
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma
Ally, A., Balasundaram, M., Carlsen, R., Chuah, E., Clarke, A., Dhalla, N., Holt, R. A., Jones, S. J. M., Lee, D., Ma, Y., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.046 · Cited by 2,490
Self-citationThe comet assay: a method to measure DNA damage in individual cells
Olive, P. L., & Banáth, J. P. (2006) · Nature Protocols · doi:10.1038/nprot.2006.5 · Cited by 1,845
Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice
Chang, J., Wang, Y., Shao, L., Laberge, R.-M., Demaria, M., Campisi, J., Janakiraman, K., Sharpless, N. E., Ding, S., Feng, W., et al. (2016) · Nature Medicine · doi:10.1038/nm.4010 · Cited by 1,819
Genetic landscape and biomarkers of hepatocellular carcinoma
Zucman-Rossi, J., Villanueva, A., Nault, J.-C., & Llovet, J. M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.061 · Cited by 1,325
Cited by
Sorted by citations
Items 301–400 of 432
Peng, X., Tang, W., Jiang, Y., Peng, A., Xiao, Y., & Zhang, Y. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117491 · Cited by 4
Dual targeting of CDK6 and LSD1 is synergistic and overcomes differentiation blockade in AML
Brault, L. M., Voisset, E., Desaunay, M., Boudet, A., Kousteridou, P., Letard, S., Carbuccia, N., Goubard, A., Castellano, R., Collette, Y., et al. (2025) · EMBO Molecular Medicine · doi:10.1038/s44321-025-00296-2 · Cited by 4
Menéndez, J. A., Lupu, R., Martín-Castillo, B., Josep Sardanyés, A., Alarcón, T., Verdura, S., & Cuyàs, E. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1695244 · Cited by 6
A Conversation with ChatGPT on Contentious Issues in Senescence and Cancer Research
Elshazly, A. M., Shahin, U., Shboul, S. A., Gewirtz, D. A., & Saleh, T. (2024) · Molecular Pharmacology · doi:10.1124/molpharm.124.000871 · Cited by 4
Li, K., Guo, C., Li, R., Yao, Y., Qiang, M., Chen, Y., Tu, K., & Xu, Y. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.109196 · Cited by 4
Cazzaniga, C., Göder, A., Rainey, M. D., Quinlan, A., Coughlan, S., Bernard, S., & Santocanale, C. (2024) · FEBS Journal · doi:10.1111/febs.17127 · Cited by 4
Zhou, Y., Yi, T., Luo, Q., HU, Y., & Peng, W. (2024) · Acta Poloniae Pharmaceutica - Drug Research · doi:10.32383/appdr/178491 · Cited by 5
Defining melanoma combination therapies that provide senolytic sensitivity in human melanoma cells
Tchelougou, D., Malaquin, N., Cardin, G. B., Desmul, J., Turcotte, S., & Rodier, F. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1368711 · Cited by 4
Comprehensive Cellular Senescence Evaluation to Aid Targeted Therapies
Zhou, X., Zhu, X., Wang, W., Wang, J., Wen, H., Zhao, Y., Zhang, J., Xu, Q., Zhao, Z., & Ni, T. (2024) · Research · doi:10.34133/research.0576 · Cited by 4
Self-citationPTBP1 enforces ATR-CHK1 signaling determining the potency of CDC7 inhibitors
Göder, A., Quinlan, A., Rainey, M. D., Bennett, D., Shamavu, D., Corso, J., & Santocanale, C. (2023) · iScience · doi:10.1016/j.isci.2023.106951 · Cited by 5
A Multi-Stage DCNN Method for Liver Tumor Segmentation
Wu, Q., Zhao, L., Lin, C., & Zhao, G. (2020) · IEEE International Conference of Safe Production and Informatization (IICSPI) · doi:10.1109/iicspi51290.2020.9332353 · Cited by 4
Cellular Senescence in Cancer: Mechanisms, Roles in Tumor Progression, and Therapeutic Implications
Yan, J., Zhang, Y., Mao, G., Yu, J., Zhou, T., & Hao, J. (2025) · MedComm – Oncology · doi:10.1002/mog2.70029 · Cited by 3
EGFR blockade confers sensitivity to pan-RAS inhibitors in KRAS-mutated cancers
Han, J., Yu, B., Jing, J., He, X., Hua, Y., & Xu, G. (2025) · Cellular Oncology · doi:10.1007/s13402-025-01075-4 · Cited by 3
Zhang, W., Jia, Y., Wang, A., Guo, R. H., Fu, Z., & Wang, W. (2025) · Tissue and Cell · doi:10.1016/j.tice.2025.103089 · Cited by 3
Self-citationA Reporter Platform to Study Therapy‐Induced Senescence in Live Cancer Cells
van de Grint, J., Huang, M., Sangers, R., Odijk, H., Reuvers, T. G. A., Heredia‐Genestar, J. M., Raams, A., Kan, T. W., Pothof, J., Kanaar, R., et al. (2025) · Small Methods · doi:10.1002/smtd.202501270 · Cited by 3
Liu, B.-B., Zhao, X.-J., Li, L.-S., Chen, P.-W., Cheng, D., Zhu, W.-Q., Zhang, W., Yuan, P., & Zhao, M.-X. (2025) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2025.137757 · Cited by 3
Bigdeli, M., Tremblay, E., Provencher, D. M., Mes‐Masson, A., & Rodier, F. (2026) · Molecular Cancer · doi:10.1186/s12943-025-02562-w · Cited by 3
Chen, X., Deng, Y. C., Yang, X., Zhang, Y., Huang, Y., Li, S., Yang, H., Shi, Q., Wu, S., Chen, S., et al. (2026) · Nature Machine Intelligence · doi:10.1038/s42256-026-01192-1 · Cited by 3
New Relevant Evidence in Cholangiocarcinoma Biology and Characterization
Porro, N., Spínola-Lasso, E., Pastore, M., Caligiuri, A., Tommaso, L. D., Marra, F., & Gentilini, A. (2024) · Cancers · doi:10.3390/cancers16244239 · Cited by 3
Zhen, W., Jiang, X., Li, E., Germanas, T., Lee, M. J., Luo, T., Ma, X., Wang, C., Chen, Y., Weichselbaum, R. R., et al. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123355 · Cited by 3
Self-citationFang, C., Li, W., Yin, R., Zhu, D., Liu, X., Wu, H., Wang, Q., Wang, W., Bai, Q., Chen, B., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-93055-5 · Cited by 3
Self-citationMani, R. J., Anand, M., Agarwal, K., Tiwari, A., Hashmi, Q. A. R., Singh, T. V., Nongdam, P., Katare, D. P., & Potshangbam, A. M. (2023) · Drugs and Drug Candidates · doi:10.3390/ddc2020013 · Cited by 3
Qu, C., Wu, Q., Lu, J., & Li, F. (2024) · Environmental Toxicology · doi:10.1002/tox.24121 · Cited by 3
RetractedElayappan, P. K., Kandasamy, K., Vadivukkarasi, S., Bharathi, M., Hirad, A. H., Alarfaj, A. A., Arulselvan, P., Jaganathan, R., Ravindran, R., Suriyaprakash, J., et al. (2024) · Biotechnology Letters · doi:10.1007/s10529-024-03491-2 · Cited by 3
Marizomib Promotes Senescence or Long-Term Apoptosis in Melanoma Cancer Cells
Piskorz, W. M., Krętowski, R., & Cechowska‐Pasko, M. (2024) · Molecules · doi:10.3390/molecules29235652 · Cited by 3
Picallos-Rabina, P., Silva‐Álvarez, S. D., Antelo-Iglesias, L., Triana-Martínez, F., & Collado, M. (2020) · Healthy ageing and longevity · doi:10.1007/978-3-030-44903-2_5 · Cited by 3
Suppression of MRPL23 induces cellular senescence in hepatocellular carcinoma by targeting HMGB1
Huang, Y.-B., Xu, S.-M., Li, M., Chen, J., Lu, C., & Liu, Q. (2025) · Discover Oncology · doi:10.1007/s12672-025-02885-6 · Cited by 2
Gene expression signatures of response to fluoxetine treatment: systematic review and meta-analyses
Cooper, D. G., Cowden, J. P., Vo, P., Stanley, P. E., Karbowski, J. T., Gaertig, V. S., Lukan, C. J., Worthington, A., & Class, C. A. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03118-6 · Cited by 2
Chen, X., Wang, J., Yan, Z., Du, X., Zhang, Z., Liu, X., Hu, L., He, K., Zhang, J., & Han, Y. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08318-0 · Cited by 2
Fang, S., Zheng, L., Lin, B., Chen, J., Hou, D., Ding, Y., Han, M., Qin, P., Wang, M., Guo, X., et al. (2025) · Advanced Science · doi:10.1002/advs.202517792 · Cited by 3
Llop‐Hernández, À., Verdura, S., López, J., Martín-Castillo, B., Menéndez, J. A., & Cuyàs, E. (2026) · Cell Death Discovery · doi:10.1038/s41420-026-02967-6 · Cited by 3
Tartiere, A. G., Roiz‐Valle, D., Español, Y., Bretones, G., Freije, J. M. P., & Ugalde, A. P. (2026) · npj Aging · doi:10.1038/s41514-026-00501-7 · Cited by 1
Immune surveillance and immune evasion of senescent cells
Garcia-Baucells, P., Serrano, M., & Amor, C. (2026) · Nature reviews. Immunology · doi:10.1038/s41577-026-01335-w · Cited by 4
A Platinum‐Aluminum Bimetallic Salen Complex for Pro‐senescence Cancer Therapy
Tang, J., Yang, Y., Yin, H., Ma, B., Zhu, M., Yang, Z., Peng, X., Jia, F., Zhao, Y., Wang, F., et al. (2024) · ChemBioChem · doi:10.1002/cbic.202400105 · Cited by 2
Jiang, X., Ping, Y., Chen, Y., Zhu, B., Fu, R., Hao, Y., & Fan, L. (2024) · Genes & Genomics · doi:10.1007/s13258-024-01515-9 · Cited by 2
Senescence and oral cancer: From mechanisms to therapeutic opportunities
Yang, Z. R., Guo, L., & Wang, B. (2025) · Translational dental research. · doi:10.1016/j.tdr.2025.100034 · Cited by 3
Cancer research driven by cutting-edge multi-disciplinary technologies
Lyu, Q., Feng, Y., Shi, R., Wu, J., & Han, W. (2020) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2020-0638 · Cited by 2
Efficacy and safety of Xiaoaiping injection for liver cancer
Hou, D., Xiong, J., Li, Y., Peng, Y., & Xiong, L. (2020) · Medicine · doi:10.1097/md.0000000000021993 · Cited by 2
Prp19 Facilitated p21-Dependent Senescence of Hepatocellular Carcinoma Cells
Yin, J., Zhang, G., Fang, Y., Yu, X., Liu, T., Dong, L., & Shen, X. (2022) · Journal of Oncology · doi:10.1155/2022/5705896 · Cited by 2
RetractedCai, Q., Wu, D., Shen, Y., Li, S., Liu, L., Liu, D., Li, Y., Chen, X., Wang, L., & Zheng, J. (2023) · Medicine · doi:10.1097/md.0000000000034365 · Cited by 2
Self-citationZhuang, H., Zhang, Z.-D., Chen, B., Tang, C.-W., Chen, X.-M., Tan, W.-L., Yang, L., Xie, Z.-Q., Ma, X.-W., Wang, Q.-B., et al. (2023) · Journal of Big Data · doi:10.1186/s40537-023-00752-1 · Cited by 1
Tsouri, E., Xu, J., Martin-Quintana, E., Akkari, L., Vegna, S., & Ando‐Kuri, M. (2025) · EMJ Hepatology · doi:10.33590/emjhepatol/qcri8208 · Cited by 1
Self-citationEvodiamine Boosts AR Expression to Trigger Senescence and Halt Proliferation in OSCC Cells
Chen, G., Du, H., Liu, J.-N., Cheng, J. J., Chen, J., Yin, X., Wei, H., & Wang, J. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47070558 · Cited by 1
Ai, N., Yuan, H., Lu, Z., Liang, Y., Lai, Q. H., Lai, L. L., Cai, H., & Ouyang, D. (2025) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbbio.2025.3599884 · Cited by 1
Wu, Y., Wang, S., Ji, S., Wang, J., Lian, S., Li, Z., Jansen, R. A., Wu, W., Niu, K., Sun, Z., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2519568122 · Cited by 1
Self-citationWang, Y., Wang, Z., Yin, Z., Song, T., He, Y., Li, M., Wang, Z., Li, Z., Wang, P., Hu, Z., et al. (2025) · Cancer Cell International · doi:10.1186/s12935-025-04111-3 · Cited by 1
¹⁹F MRI radiomic features: in vitro and in vivo repeatability
Maxouri, O., Daal, M. R. R., Vegna, S., Sánchez, D. I. R., Rostami, S., Ursprung, S., Boeije, M., Proost, N., van de Ven, M., Akkari, L., et al. (2026) · European Radiology Experimental · doi:10.1186/s41747-026-00694-2 · Cited by 1
Self-citationMi, W., Xia, X., Xue, Y., Li, L., Yang, L., Yang, X., Xu, J., Cai, X., Zhou, Y., Zhu, L., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117487 · Cited by 1
Dysregulated Lipid Metabolism in Hepatocellular Carcinoma: Mechanisms and Therapeutic Strategies
Yi, Y., Liu, X., Zhang, X., Li, Y., & Zhao, H. (2026) · MedComm – Oncology · doi:10.1002/mog2.70081 · Cited by 1
Tsouri, E., Athanasopoulou, N., Akkari, L., & Vegna, S. (2026) · Seminars in Immunology · doi:10.1016/j.smim.2026.102053 · Cited by 1
Self-citationEfficacy and safety of Xiaoaiping injection for breast cancer
Hou, D., Xiong, J., Peng, Y., Li, Y., & Xiong, L. (2020) · Medicine · doi:10.1097/md.0000000000021932 · Cited by 1
Tie, S., Tong, T., Zhan, G., Li, X., Ouyang, D., & Cao, J. (2024) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000002074 · Cited by 2
Caspase 7 mutations and their activators
Sahu, S. K., Kaur, C., Yadav, A., Potale, Y., Kaur, P., Jain, S., & Vaidya, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15644-1.00006-7 · Cited by 1
Ganesan, S., Upadhye, V. J., Aulakh, D., Bishnoi, S., Chinnathambi, A., Alahmadi, T. A., Abudoleh, S. M., Arulselvan, P., & Thangavelu, I. (2024) · Journal of Applied Polymer Science · doi:10.1002/app.56262 · Cited by 1
Zhu, Y., & Zhang, P. (2025) · Scientific Reports · doi:10.1038/s41598-025-96488-4 · Cited by 1
Chloroquine Enhances Chemosensitivity of Breast Cancer via mTOR Inhibition
Lin, Z., Xu, Y., Li, M., Liu, Y., Yu, J., & Zhang, L. (2025) · Biomedicines · doi:10.3390/biomedicines13040948 · Cited by 1
Yin, Y., Liu, Y., Lu, Y., Tang, Z., Zhu, Z., Zhu, M., Chen, H., Hui, H., Xu, J., & Li, H. (2025) · The FASEB Journal · doi:10.1096/fj.202500962rr · Cited by 1
He, J., Xu, B., Gao, W., Su, G., Yu, H., Shen, Y., & Liu, X. (2020) · PubMed Central · doi:10.7507/1001-5515.201907044 · Cited by 1
Hao Zhao1, X. L. (2023) · Academic Journal of Medicine & Health Sciences · doi:10.25236/ajmhs.2023.041203 · Cited by 1
Exploiting convergent evolution to derive a pan-cancer cisplatin response gene expression signaturePreprint
Scarborough, J. A., Eschrich, S. A., Torres–Roca, J. F., Dhawan, A., & Scott, J. G. (2021) · medRxiv · doi:10.1101/2021.11.10.21265799 · Cited by 1
Misale, S., Yaeger, R. D., Mezzadra, R., Sinopoli, J. C., Bian, Y., Marasco, M., Kaplun, E., Gao, Y., Zhao, H., Paula, A. D. C., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1236956/v1 · Cited by 1
Pooled CRISPR KO Screens for Target Identification
Grotz, A. K., & Deswal, S. (2022) · Wiley eBooks · doi:10.1002/9781119671404.ch8 · Cited by 1
Yang, X., Zhou, T., Xia, Y., Tian, H., Cheng, X., Cao, Y., Ma, H., Qin, A., & Zhao, J. (2021) · Research Square · doi:10.21203/rs.3.rs-952431/v1 · Cited by 1
Fatty acid desaturation controls cellular fate decisions between senescence and ferroptosis
Kuehnemann, C., Jezak, S. T., Mogck, B. A., Kura, N., Tariq, R., Che, Y., Vaittinen, M., Siokas, I., Deshpande, S., Guthrie, C., et al. (2026) · Cell · doi:10.1101/2024.10.03.616257 · Cited by 1
Combating pancreatic cancer during its Rip Van Winkle sleep
Görgülü, K., Lesina, M., & Algül, H. (2020) · Cell Research · doi:10.1038/s41422-020-0348-z
Cyclin-dependent kinase 2 (Cdk2) controls phosphatase-regulated signaling and function in plateletsPreprint
Woods, P. R., Hood, B. L., Shiva, S., Conrads, T. P., Suchko, S., & Steinman, R. A. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.31.126953
Birth and death of cellular senescence
Wang, B. (2020) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.131223530
Küpper, M. (2020) · World Journal of Oncology Research · doi:10.15379/2413-7308.2020.06.01
Lethal lipotoxicity for liver cancer therapy
Gallage, S., Avila, J. E. B., & Heikenwalder, M. (2021) · Nature Cancer · doi:10.1038/s43018-021-00175-y
Potential Prognostic and Therapeutic Target of CDC7 in Hepatocellular CarcinomaPreprint
Liu, R., Gan, L., Zhang, Z., Liu, X., Zhong, L., Zhao, Y., & Huang, Y. Z. (2021) · Research Square · doi:10.21203/rs.3.rs-641378/v1
A novel transcriptomic-based classifier for senescent cancer cells
Varughese, F. M., & Demaria, M. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.09.001
3-HAA Metabolic Pathway Regulates HCC GrowthPreprint
Shi, Z.-P., Gan, G.-F., Gao, X., Chen, F.-X., & Mi, J. (2021) · Research Square · doi:10.21203/rs.3.rs-898525/v1
Sahu, A. D., Wang, X., Munson, P. B., Klomp, J. P. G., Wang, X., Gu, S. S., Qian, G., Nicol, P. B., Zeng, Z., Wang, C., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.25.465724
Self-citationImproving cancer therapy through unconventional strategies
Neto, J. M. F. (2021) · Utrecht University Repository (Utrecht University) · doi:10.33540/1009
Развитие субъектной позиции в младшем школьном возрасте как задача образовательного процесса
Геннадьевна, О. Н. (2012) · Omsk Scientific Bulletin
Qin, W., Zhou, Y., Wang, S., Wu, W., Jing, L., Li, H., Jia, Q., Zheng, J., Zheng, X., Yu, R., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1452915/v1
Self-citationZhu, G., Tang, Z., Huang, R., Qu, W., Fang, Y., Jiang, X., Tao, C., Gao, J., Wu, X., Sun, H., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4065079
Tian, X., Li, J., Zhang, Y., Gao, Y. J., Afzal, M. W., Wang, A., James, T. D., Bai, Y., & Guo, Y. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3997563
Faculty Opinions recommendation of Senolytic CAR T cells reverse senescence-associated pathologies.
Pawelec, G. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.738152729.793576459
Yu, Y., Wang, Z., Huang, Z., Tang, X., & Li, W. (2020) · Research Square · doi:10.21203/rs.3.rs-80702/v1
High LRRC1 expression indicates poor prognosis of hepatocellular carcinomaPreprint
Cai, Q., Wu, D., Shen, Y., Li, S., Liu, L., Liu, D., & Zheng, J. (2022) · Research Square · doi:10.21203/rs.3.rs-1849971/v1
Preclinical evaluation of senescence-based strategies to improve cancer therapy
Estepa‐Fernández, A. (2022) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/188845
Patent Highlights June–July 2022
Mucke, H. A. (2022) · Pharmaceutical Patent Analyst · doi:10.4155/ppa-2022-0043
High LRRC1 expression indicates poor prognosis of hepatocellular carcinomaPreprint
Cai, Q., Wu, D., Shen, Y., Li, S. L., Liu, L., Liu, D., Li, Y., Chen, X., Wang, L., & Zheng, J. (2022) · Research Square · doi:10.21203/rs.3.rs-1849971/v2
Self-citationLiu, H. S., & Wu, N. (2022) · Science of Advanced Materials · doi:10.1166/sam.2022.4277
Zhou, M., Liao, X. H., & Xu, T. (2022) · International Conference on Bioinformatics and Biomedical Science (ICBBS) · doi:10.1145/3571532.3571535
Senotherapy as a Novel Therapeutic Method in Cancer Treatment: With a Focus on Head and Neck Cancer
Ziaei, H., & Harada, H. (2023) · Interdisciplinary cancer research · doi:10.1007/16833_2022_118
MULTI-SCALE ATTENTION BASED U-NET MODEL FOR LIVER TUMOR SEGMENTATION
Jenisha, J. R., & Dickson, A. (2023) · EPRA International Journal of Research & Development (IJRD) · doi:10.36713/epra12576
Sahu, A. D., Wang, X., Munson, P. B., Klomp, J. P. G., Wang, X., Gu, S. S., Han, Y., Qian, G., Nicol, P. B., Zeng, Z., et al. (2023) · doi:10.1158/2159-8290.22543005
Self-citationWang, X., Jowsey, W. J., Cheung, C., Seeto, N. E. J., Waller, N. J. E., Chrisp, M. T., Peterson, A. L., Nijagal, B., Fineran, P. C., Cook, G. M., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.07.570702
Wu, Y., Zhou, H., Zhou, Q., & Xu, Y. (2024) · Clinical and Translational Discovery · doi:10.1002/ctd2.262
Machine learning recognises senescence in glioblastoma and discovers senescence-inducing compoundsPreprint
Martin, L., Irving, A., Suwanlikit, Y., Morrison, G. M., Elliott, R. J. R., Carragher, N. O., Pollard, S. M., & Chandra, T. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.03.587883
Guo, Y., Wang, J., Benedict, B., Chen, Y., van Gemert, F. P. A., Ma, X., Gao, D., Wang, H., Zhang, S., Lieftink, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16829569
Self-citationGuo, Y., Wang, J., Benedict, B., Chen, Y., van Gemert, F. P. A., Ma, X., Gao, D., Wang, H., Zhang, S., Lieftink, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16829560
Self-citationHuang, J., Huang, S., Li, G., Huang, G., Huang, Z.-S., Su, S., & Zhong, T. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.139073
RetractedQiu, Y., Wu, X., Luo, Y., Shen, L., Guo, A., Jiang, J., Zhu, L., Zhang, Y., Han, F., & Yu, E. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-01556-8
circSATB1 Modulates Cell Senescence in Age-Related Acute Myeloid Leukemia: A Mechanistic Proposal
Han, L., Wen, X., Zhang, L., Yang, X., Wei, Z., Wu, H., Zhan, Y., Wang, H., & Yu, F. (2025) · Cells · doi:10.3390/cells14151181
Targeting cellular senescence for cancer therapy
Abduljabbar, R., Liu, Y., Mussa, A., Abdu, A. M. A., Man, Y., Chen, Q., & Liu, Z. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.126297
Wang, K., Jiang, X., Jiang, Y., Liu, J., Du, Y., Zhang, Z., Li, Y., Zhao, X., Li, J., & Zhang, R. (2023) · Figshare · doi:10.6084/m9.figshare.24636466
Liu, L., Wang, Q., Wu, L., Zhang, L., Huang, Y., Yang, H., guo, L., Fang, Z., & Wang, X. (2023) · Figshare · doi:10.6084/m9.figshare.23689653
Metadata
- Authors
- Wang, C., Vegna, S., Jin, H., Benedict, B., Lieftink, C., Ramirez, C., de Oliveira, R. L., Morris, B., Gadiot, J., Wang, W., du Chatinier, A., Wang, L., Gao, D., Evers, B., Jin, G., Xue, Z., Schepers, A., Jochems, F., Sanchez, A. M., Mainardi, S., te Riele, H., Beijersbergen, R. L., Qin, W., Akkari, L., & Bernards, R.
- Affiliations
- Shanghai Jiao Tong University (CN)
- The Netherlands Cancer Institute (NL)
- Fudan University (CN)
- Corresponding author
- Qin, Wenxin
- Akkari, Leila
- Bernards, René
- ORCID
- Venue
- Nature
- Published
- 2019-10-02
- Volume
- 574
- Issue
- 7777
- Pages
- 268-272
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC6858884
- OpenAlex
- W2977409903
- Cited by
- 427
- References
- 31
- Citations by year
- 2026: 29 · 2025: 51 · 2024: 85 · 2023: 64 · 2022: 66 · 2021: 67 · 2020: 63
- FWCI
- 33.96
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- hepatocellular carcinoma, liver cancer, senescence, senolysis, TP53 mutation, sertraline, mTOR signaling, apoptosis, drug combination therapy, kinome screen, antidepressant repurposing
- MeSH terms
- Animals, Disease Models, Animal, Female, Liver Neoplasms, Male, Mice, Inbred BALB C, Mutation, Signal Transduction, Tumor Suppressor Protein p53, Cellular Senescence, Apoptosis, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Sertraline, Cell Line, Tumor, Mice, TOR Serine-Threonine Kinases, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
